Skip to main content
Equibles

Driehaus Capital Management LLC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 938206 Chicago, IL
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,988,233
-$44,979,435 QoQ
Shares Held
317,576
-65.7% QoQ
Ownership
0.724%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#34
of 256 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority Sole 78% Shared 0% None 22%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,707,249,767 across 60 Biotechnology names. TARS ranks #34 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 6,845,276 $322,001,783
2 PRAX
Praxis Precision Medicines, Inc.
 959,048 $321,079,679
3 XENE
Xenon Pharmaceuticals Inc.
 4,418,557 $266,704,100
4 SYRE
Spyre Therapeutics, Inc.
 2,799,166 $248,509,957
5 CRNX
Crinetics Pharmaceuticals, Inc.
 6,463,551 $241,866,078
6 APGE
Apogee Therapeutics, Inc.
 1,740,101 $230,963,605
7 EWTX
Edgewise Therapeutics, Inc.
 4,728,623 $192,123,952
8 SEPN
Septerna, Inc.
 4,433,058 $148,463,112

All Filings in TARS

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,988,233 317,576
2026-03-31 $64,967,668 926,125
2025-12-31 $95,998,322 1,172,427
2025-09-30 $61,274,766 1,031,041
2025-06-30 $35,508,918 876,547
2025-03-31 $36,876,108 717,853
2024-06-30 $9,906,104 364,463
2024-03-31 $5,858,275 161,163